Management Team

Dr Kenneth Tsang was appointed as Regional Chief Executive Officer, IHH Healthcare North Asia, effective from 1 April 2024. In conjunction with his role as Chief Executive Officer of Gleneagles Hospital Hong Kong, he provides oversight for Gleneagles Hospital, Gleneagles Healthcare ambulatory care centres and primary clinics, and Parkway Laboratory Services in Hong Kong. His strategic leadership, including his position as Chairman of IHH China Operations Steering Committee, plays a pivotal role in advancing our operations in China towards sustainable long-term growth.

Dr Tsang joined Gleneagles Hospital Hong Kong in 2019 as Chief Operating Officer before rising to become its Chief Executive Officer in 2021.

Prior to IHH, Dr Tsang was with the Hospital Authority in Hong Kong for over 25 years, first as a practising physician in Queen Elizabeth Hospital before becoming a full-time medical administrator at its Head Office, taking up management roles in patient safety, strategy and service planning, infection control and cluster services.

Dr Tsang is a Fellow of the Hong Kong Academy of Medicine (Community Medicine), Fellow of the Hong Kong College of Community Medicine and a Fellow of The Royal Australasian College of Medical Administrators. He is also an Honorary Clinical Associate Professor of School of Public Health, Li Ka Shing Faculty of Medicine of The University of Hong Kong.

Academic/Professional Qualification(s)

• Bachelor of Medicine & Surgery, The University of Hong Kong
• Master of Occupational Medicine, The Chinese University of Hong Kong

Notes

• Does not have any family relationships with any directors and / or major shareholders of the Company.
• Does not have any conflict of interest with the Company.
• Does not have any convictions for offences within the past five years other than for traffic offences, if any.